KYNAMRO Risk Evaluation and Mitigation Strategy (REMS) is an FDA-required program to educate healthcare providers and patients in order to ensure that KYNAMRO is prescribed only to patients for whom the benefits outweigh the risks.
Having a rare and serious medical condition can make you feel alone and at times even lost. Along with your doctor and healthcare team, who are always your best resources for information on your health, the COMPASS Program is here to help.
COMPASS is a fr